Targeted Therapy and Chemotherapy-Associated Skin Toxicities: Systematic Review and Meta-Analysis

August 2020 in “ Oncology nursing forum ”

Jingyi Ding, Magdoleen H. Farah, Tarek Nayfeh, Konstantinos Malandris, Apostolos Manolopoulos, Pamela Ginex, Bashar Hasan, Hayley Dunnack Yackel, Rami Abd‐Rabu, Moutie Rajjoub, Larry J. Prokop, Rebecca L. Morgan, M. Hassan Murad

minocycline erlotinib pyridoxine hand-foot syndrome capecitabine scalp cooling alopecia chemotherapy acneform rash hair loss total alopecia

TLDR Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

This systematic review and meta-analysis evaluated interventions for preventing and managing skin toxicities related to cancer treatments, including data from 39 studies with 6,006 patients. Prophylactic minocycline was found to reduce acneform rash in patients treated with erlotinib, while pyridoxine 400 mg lowered the risk of hand-foot syndrome in capecitabine-treated patients. Scalp cooling was effective in reducing severe hair loss or total alopecia associated with chemotherapy. However, the certainty of evidence for several interventions was limited, indicating a need for further research.

View this study on onf.ons.org →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Efficacy and Tolerability of Two Scalp Cooling Systems for the Prevention of Alopecia Associated with Docetaxel Treatment

52 citations, May 2013 in “Supportive Care in Cancer”

Scalp cooling significantly reduces hair loss in chemotherapy patients.

research Efficacy of Penguin Cap as Scalp Cooling System for Prevention of Alopecia in Patients Undergoing Chemotherapy

27 citations, June 2011 in “Journal of Advanced Nursing”

The penguin cap can help reduce hair loss in chemotherapy patients.

research The PRIDE Syndrome: Dermatological Side Effects of EGFR Inhibitors

90 citations, August 2006 in “British Journal of Dermatology”

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

Similar Research

5 / 430 results

research Cutaneous Adverse Effects of Targeted Therapies

192 citations, January 2015 in “Journal of the American Academy of Dermatology”

Targeted cancer therapies often cause serious skin problems that need careful management.

research Chemotherapy-Induced Iatrogenic Injury of Skin: New Drugs and New Concepts

19 citations, October 2011 in “Clinics in Dermatology”

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

research Skin Toxicity of Anti-Cancer Therapy

19 citations, October 2008 in “Journal der Deutschen Dermatologischen Gesellschaft”

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

research Chemotherapy and Cutaneous Drug Reactions

1 citations, January 2015 in “Springer eBooks”

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

research Prevention And Management Of Dermatological Toxicities Related To Anticancer Agents: ESMO Clinical Practice Guidelines

86 citations, November 2020 in “Annals of Oncology”

Early intervention and tailored management can reduce skin side effects from cancer treatments.